Bleakley Financial Group »

Disc Medicine shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Disc Medicine (IRON) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Disc Medicine

Tip: Access up to 7 years of quarterly data

All positions including Disc Medicine held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Disc Medicine by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2024-12-31 $486k 7.7k 63.40
2024-03-31 $285k 4.6k 62.26
2023-12-31 $215k 3.7k 57.76

More positions owned by Bleakley Financial Group

Sprott Asset Management Physical Gold An (CEF)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Ishares Tr Core S&p500 Etf (IVV)
Amazon (AMZN)
Sprott Asset Management Physical Gold Tr (PHYS)
Vanguard Intl Equity Index F Tt Wrld St Etf (VT)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)

View all positions for Bleakley Financial Group

Top funds holding Disc Medicine

FMR
Atlas Venture Life Science Advisors
BlackRock
Vanguard Group
RA Capital Management
Frazier Life Sciences Management
OrbiMed Advisors
Wellington Management Company
State Street Corporation
Deerfield Management Company
Siren
Woodline Partners
Jpmorgan Chase & Co
Geode Capital Management
Jennison Associates

View all funds holding Disc Medicine